The Year Strategy Meets Scale: Brillio’s Beyond the Curve 2026 Charts the Enterprise AI Roadmap
DALLAS, Feb. 3, 2026 /PRNewswire/ -- Brillio today unveiled Beyond the Curve 2026, a…
Role of CathWorks FFRangio for the Assessment of Coronary Artery Disease Now Reinforced by SCAI Expert Opinion
NEWPORT BEACH, Calif., Feb. 3, 2026 /PRNewswire/ -- CathWorks, a global leader…
Metabolon Names Andrew Messick Chief Financial Officer
Seasoned life sciences finance leader brings deep expertise in operational excellence and…
NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer
NEW YORK, Feb. 3, 2026 /PRNewswire/ -- The New York Stock Exchange…
Skin Aesthete Becomes Navi Mumbai’s Only Clinic to Offer EMFACE, Redefining Non-Invasive Facial Rejuvenation
MUMBAI, India, Feb. 3, 2026 /PRNewswire/ -- Skin Aesthete, the premium dermatology…
21 Asian Countries Among 93 Worldwide at Risk of Losing Nearly 23 Million More People by 2030
ISGlobal, supported by Rockefeller Foundation, analyzed impact of severe global aid cuts…
Berry Street Named to 2026 New York Digital Health 100 List
Digital Health New York recognizes nutrition therapy platform’s innovative approach to evidence-based…
Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Initiation of trial marks first-in-human milestone for Neomorph’s novel molecular glue degrader…
RESTEM Announces First Patient Dosed in the Phase 2/3 IIMPACT Study of Restem-L in Idiopathic Inflammatory Myopathy
February 03, 2026 13:06 ET | Source: Restem Initiation of the IIMPACT…
Cango Inc. Announces January 2026 Bitcoin Production and Mining Operations Update
DALLAS, Feb. 3, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or…
